 | • レポートコード：B-GIR09D4161 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、癌治療における新薬デリバリーシステムの世界市場について調べ、まとめました。種類別セグメントは、ナノ粒子、液体塞栓、塞栓粒子等、用途別セグメントは、病院及び診療所、癌治療センター、その他等に区分しました。癌治療における新薬デリバリーシステムの世界市場概観、企業動向、企業別癌治療における新薬デリバリーシステムシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・癌治療における新薬デリバリーシステムの市場概観 ・癌治療における新薬デリバリーシステムの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・癌治療における新薬デリバリーシステムの企業別販売動向、市場シェア、市場集中度、競争動向 ・癌治療における新薬デリバリーシステムの世界市場規模 ・癌治療における新薬デリバリーシステムの北米市場分析（アメリカ、カナダ、メキシコ等） ・癌治療における新薬デリバリーシステムのアメリカ市場規模推移 ・癌治療における新薬デリバリーシステムのカナダ市場規模推移 ・癌治療における新薬デリバリーシステムのメキシコ市場規模推移 ・癌治療における新薬デリバリーシステムのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・癌治療における新薬デリバリーシステムのドイツ市場規模推移 ・癌治療における新薬デリバリーシステムのイギリス市場規模推移 ・癌治療における新薬デリバリーシステムのロシア市場規模推移 ・癌治療における新薬デリバリーシステムのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・癌治療における新薬デリバリーシステムの日本市場規模推移 ・癌治療における新薬デリバリーシステムの中国市場規模推移 ・癌治療における新薬デリバリーシステムの韓国市場規模推移 ・癌治療における新薬デリバリーシステムのインド市場規模推移 ・癌治療における新薬デリバリーシステムの東南アジア市場規模推移 ・癌治療における新薬デリバリーシステムの南米市場分析（ブラジル、アルゼンチン等） ・癌治療における新薬デリバリーシステムの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・癌治療における新薬デリバリーシステムの種類別分析/販売量、売上、市場シェア（ナノ粒子、液体塞栓、塞栓粒子） ・癌治療における新薬デリバリーシステムの用途別分析/市場規模（病院及び診療所、癌治療センター、その他） ・癌治療における新薬デリバリーシステムの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・癌治療における新薬デリバリーシステムの販売チャネル・代理店・貿易業者・ディーラー分析 |
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
Scope of the Report:
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
The global Novel Drug Delivery Systems in Cancer Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Novel Drug Delivery Systems in Cancer Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Novel Drug Delivery Systems in Cancer Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Novel Drug Delivery Systems in Cancer Therapy market by product type and applications/end industries.
Market Segment by Companies, this report covers
Teva
Johnson & Johnson
Roche
Takeda
AbbVie
Samyang Biopharmaceuticals
Celgene
Spectrum Pharmaceuticals, Inc.
Gilead Sciences
Shire (Baxalta)
Merrimack
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Nanoparticles
Liquid Embolics
Embolization Particles
Market Segment by Applications, can be divided into
Hospitals & Clinic
Cancer Treatment Centers
Others
Table of Contents
1 Novel Drug Delivery Systems in Cancer Therapy Market Overview
1.1 Product Overview and Scope of Novel Drug Delivery Systems in Cancer Therapy
1.2 Classification of Novel Drug Delivery Systems in Cancer Therapy by Types
1.2.1 Global Novel Drug Delivery Systems in Cancer Therapy Revenue Comparison by Types (2019-2024)
1.2.2 Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Types in 2018
1.2.3 Nanoparticles
1.2.4 Liquid Embolics
1.2.5 Embolization Particles
1.3 Global Novel Drug Delivery Systems in Cancer Therapy Market by Application
1.3.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals & Clinic
1.3.3 Cancer Treatment Centers
1.3.4 Others
1.4 Global Novel Drug Delivery Systems in Cancer Therapy Market by Regions
1.4.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Novel Drug Delivery Systems in Cancer Therapy Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Novel Drug Delivery Systems in Cancer Therapy Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Novel Drug Delivery Systems in Cancer Therapy Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Novel Drug Delivery Systems in Cancer Therapy Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Novel Drug Delivery Systems in Cancer Therapy Status and Prospect (2014-2024)
1.5 Global Market Size of Novel Drug Delivery Systems in Cancer Therapy (2014-2024)
2 Manufacturers Profiles
2.1 Teva
2.1.1 Business Overview
2.1.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Teva Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.3 Roche
2.3.1 Business Overview
2.3.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.4 Takeda
2.4.1 Business Overview
2.4.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Takeda Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.5 AbbVie
2.5.1 Business Overview
2.5.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AbbVie Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.6 Samyang Biopharmaceuticals
2.6.1 Business Overview
2.6.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.7 Celgene
2.7.1 Business Overview
2.7.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Celgene Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.8 Spectrum Pharmaceuticals, Inc.
2.8.1 Business Overview
2.8.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Spectrum Pharmaceuticals, Inc. Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.9 Gilead Sciences
2.9.1 Business Overview
2.9.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Gilead Sciences Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.10 Shire (Baxalta)
2.10.1 Business Overview
2.10.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Shire (Baxalta) Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.11 Merrimack
2.11.1 Business Overview
2.11.2 Novel Drug Delivery Systems in Cancer Therapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Merrimack Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
3 Global Novel Drug Delivery Systems in Cancer Therapy Market Competition, by Players
3.1 Global Novel Drug Delivery Systems in Cancer Therapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Novel Drug Delivery Systems in Cancer Therapy Players Market Share
3.2.2 Top 10 Novel Drug Delivery Systems in Cancer Therapy Players Market Share
3.3 Market Competition Trend
4 Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Regions
4.1 Global Novel Drug Delivery Systems in Cancer Therapy Revenue and Market Share by Regions
4.2 North America Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
4.3 Europe Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
4.5 South America Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
5 North America Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries
5.1 North America Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries (2014-2019)
5.2 USA Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
5.3 Canada Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
5.4 Mexico Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
6 Europe Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries
6.1 Europe Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries (2014-2019)
6.2 Germany Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
6.3 UK Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
6.4 France Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
6.5 Russia Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
6.6 Italy Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries
7.1 Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries (2014-2019)
7.2 China Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
7.3 Japan Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
7.4 Korea Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
7.5 India Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
8 South America Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries
8.1 South America Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries (2014-2019)
8.2 Brazil Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
8.3 Argentina Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
8.4 Colombia Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Novel Drug Delivery Systems in Cancer Therapy by Countries
9.1 Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
9.3 UAE Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
9.4 Egypt Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
9.6 South Africa Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
10 Global Novel Drug Delivery Systems in Cancer Therapy Market Segment by Type
10.1 Global Novel Drug Delivery Systems in Cancer Therapy Revenue and Market Share by Type (2014-2019)
10.2 Global Novel Drug Delivery Systems in Cancer Therapy Market Forecast by Type (2019-2024)
10.3 Nanoparticles Revenue Growth Rate (2014-2024)
10.4 Liquid Embolics Revenue Growth Rate (2014-2024)
10.5 Embolization Particles Revenue Growth Rate (2014-2024)
11 Global Novel Drug Delivery Systems in Cancer Therapy Market Segment by Application
11.1 Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Application (2014-2019)
11.2 Novel Drug Delivery Systems in Cancer Therapy Market Forecast by Application (2019-2024)
11.3 Hospitals & Clinic Revenue Growth (2014-2019)
11.4 Cancer Treatment Centers Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Novel Drug Delivery Systems in Cancer Therapy Market Size Forecast (2019-2024)
12.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size Forecast (2019-2024)
12.2 Global Novel Drug Delivery Systems in Cancer Therapy Market Forecast by Regions (2019-2024)
12.3 North America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
12.4 Europe Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
12.6 South America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Novel Drug Delivery Systems in Cancer Therapy Picture
Table Product Specifications of Novel Drug Delivery Systems in Cancer Therapy
Table Global Novel Drug Delivery Systems in Cancer Therapy and Revenue (Million USD) Market Split by Product Type
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Types in 2018
Figure Nanoparticles Picture
Figure Liquid Embolics Picture
Figure Embolization Particles Picture
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) by Application (2014-2024)
Figure Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Applications in 2018
Figure Hospitals & Clinic Picture
Figure Cancer Treatment Centers Picture
Figure Others Picture
Table Global Market Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Teva Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Johnson & Johnson Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Roche Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Takeda Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table AbbVie Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Samyang Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Samyang Biopharmaceuticals Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Samyang Biopharmaceuticals Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Celgene Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Spectrum Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table Spectrum Pharmaceuticals, Inc. Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Spectrum Pharmaceuticals, Inc. Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Gilead Sciences Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Shire (Baxalta) Basic Information, Manufacturing Base and Competitors
Table Shire (Baxalta) Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Shire (Baxalta) Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Merrimack Basic Information, Manufacturing Base and Competitors
Table Merrimack Novel Drug Delivery Systems in Cancer Therapy Type and Applications
Table Merrimack Novel Drug Delivery Systems in Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) by Players (2014-2019)
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue Share by Players (2014-2019)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Share by Players in 2017
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Share by Players in 2018
Figure Global Top 5 Players Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share in 2018
Figure Global Top 10 Players Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share in 2018
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) by Regions (2014-2019)
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Regions in 2018
Figure North America Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Europe Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure South America Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Table North America Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries (2014-2019)
Table North America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries in 2018
Figure USA Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Canada Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Mexico Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Table Europe Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure Europe Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries in 2018
Figure Germany Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure UK Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure France Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Russia Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Italy Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries in 2018
Figure China Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Japan Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Korea Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure India Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Table South America Novel Drug Delivery Systems in Cancer Therapy Revenue by Countries (2014-2019)
Table South America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries in 2018
Figure Brazil Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Argentina Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Colombia Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure UAE Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Egypt Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Nigeria Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure South Africa Novel Drug Delivery Systems in Cancer Therapy Revenue and Growth Rate (2014-2019)
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) by Type (2014-2019)
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue Share by Type (2014-2019)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Share by Type (2014-2019)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Share by Type in 2019
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue Forecast by Type (2019-2024)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Market Share Forecast by Type (2019-2024)
Figure Global Nanoparticles Revenue Growth Rate (2014-2019)
Figure Global Liquid Embolics Revenue Growth Rate (2014-2019)
Figure Global Embolization Particles Revenue Growth Rate (2014-2019)
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue by Application (2014-2019)
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue Share by Application (2014-2019)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Share by Application (2014-2019)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Share by Application in 2019
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue Forecast by Application (2019-2024)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Market Share Forecast by Application (2019-2024)
Figure Global Hospitals & Clinic Revenue Growth Rate (2014-2019)
Figure Global Cancer Treatment Centers Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Novel Drug Delivery Systems in Cancer Therapy Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
Figure Europe Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
Figure South America Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Novel Drug Delivery Systems in Cancer Therapy Revenue Market Forecast (2019-2024)
世界のがんにおける薬物デリバリー市場予測（～2024年） Scope of the Report: The global Drug Delivery in Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, a…- がん薬物療法市場：世界及び中国市場分析・予測（～2024年） Cancer Drug Therapy Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cancer Drug Therapy industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cancer Drug Therapy manufactur…
- ドラッグデリバリーシステム市場：世界及び中国市場分析・予測（～2024年） Drug Delivery Systems Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Drug Delivery Systems industry with a focus on the Chinese market. The report provides key statistics on the market status of the Drug Delivery Systems manu…
- 植込み型ドラッグデリバリーシステム市場：世界及び中国市場分析・予測（～2024年） Implantable Drug Delivery Systems Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Implantable Drug Delivery Systems industry with a focus on the Chinese market. The report provides key statistics on the market status of the Im…
- 単位用量薬物送達システム市場：世界及び中国市場分析・予測（～2024年） Unit Dose Drug Delivery Systems Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Unit Dose Drug Delivery Systems industry with a focus on the Chinese market. The report provides key statistics on the market status of the Unit D…